Praxis Precision Medicines, Inc. (PRAX)
245.76
-2.48
(-1.00%)
USD |
NASDAQ |
Oct 16, 12:23
Praxis Precision Medicines SG&A Expense (TTM) : 87.46M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.46M |
| March 31, 2026 | 73.03M |
| December 31, 2025 | 59.08M |
| September 30, 2025 | 54.68M |
| June 30, 2025 | 57.37M |
| March 31, 2025 | 54.89M |
| December 31, 2024 | 56.30M |
| September 30, 2024 | 51.11M |
| June 30, 2024 | 44.58M |
| March 31, 2024 | 44.12M |
| December 31, 2023 | 42.05M |
| September 30, 2023 | 45.24M |
| June 30, 2023 | 50.37M |
| March 31, 2023 | 57.02M |
| Date | Value |
|---|---|
| December 31, 2022 | 59.95M |
| September 30, 2022 | 61.97M |
| June 30, 2022 | 59.75M |
| March 31, 2022 | 53.78M |
| December 31, 2021 | 47.08M |
| September 30, 2021 | 41.37M |
| June 30, 2021 | 33.17M |
| March 31, 2021 | 24.88M |
| December 31, 2020 | 16.99M |
| September 30, 2020 | 9.347M |
| June 30, 2020 | 7.224M |
| March 31, 2020 | 4.704M |
| December 31, 2019 | 3.103M |
| September 30, 2019 | 1.308M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| BioMarin Pharmaceutical, Inc. | 1.368B |
| Insmed, Inc. | 893.58M |
| Vertex Pharmaceuticals, Inc. | 2.008B |
| Ironwood Pharmaceuticals, Inc. | 64.55M |
| Xencor, Inc. | 65.28M |